Located in the Greater Seattle Area,
Celogics develops high-quality human induced pluripotent stem cell products to advance drug discovery, safety screening, and therapeutics research.
What We Offer
iPSC-derived Cell Products
for Disease Modeling, Drug Discovery, and Drug Safety Screening
We aim to become the Next-generation cell manufacturer
Precisely designed functional iPSC-derived cardiomyocytes with human CM-like electrophysiology validated in multiple platforms.
From 2D cultures to 3D organoids, our Celo.CMs are developed to maintain their functionality and electrophysiology.
We aim to bring INNOVATION to current CDMO market
Our human iPSC-derived cell products focus on providing validated data to make sure users are satisfied with their experience.
Good communication with our users is central in ensuring you get a reliable product and accelerate the diverse projects you are working on.
Celogics strives to make quality human cells that are not just great iPSC-derived cells but the best functional cells.
No compromises made when it comes to quality - Our comprehensive quality control processes are crucial to our business.